![]() |
Mr. Everist attended Stanford University from 1993-1997 and studied Product Design. He worked at Mongo Music, an online music search engine, from 1998 to 2000. Steve was involved from the earliest days of the company with development of search and categorization technology there. MongoMusic sold to Microsoft in 2000 for 65m and became part of MSN Music where he worked until 2001 coding. Steve worked with TeraCloud, an SRM company based in Seattle, for the next year. Steve realized at MongoMusic that his growing interest in Information Science was best served in the Life Sciences. He finished the Stanford Online course offerings in BioInformatics by 2001. Steve spent 2002 sailing from Seattle to Florida via the Panama Canal onboard his 35' sloop StarThrower with his brother Mike. Steve then joined Genetics Squared (now Everist Genomics) in late 2003 where he worked on product development. He has been working with The Everist Company, a 5th generation family business, since 2006 as a director and project manager on several of the company's assets. |
|
Dr. Peter Lenehan brings to Everist Genomics a combined 25 years of basic cancer research, internal medicine, clinical hematology/oncology, and pharmaceutical industry experience. Dr. Lenehan’s wide depth and breadth of biomedical expertise provides him a unique perspective on the most significant unmet needs in medicine. This experience enables him to provide critical clinical input to optimally identify, develop and commercialize all of the company’s products. As the Chief Medical Officer, Dr. Lenehan has been instrumental in drafting the studies needed to generate and validate the company’s genomic prognostic signatures for cancer. He has successfully established long-term working relationships with numerous tissue biobanks and fostered collaborations with major academic institutions in the US, Canada, and India, where clinical cardiovascular device studies are either being conducted or planned. After completing his doctoral studies at the Sloan-Kettering Institute for Cancer Research in New York City, Dr. Lenehan received his MD and a PhD in Cell Biology from the State University of New York. He subsequently completed an Internal Medicine residency at Thomas Jefferson University in Philadelphia and a Hematology/Oncology fellowship at the University of Maryland Cancer Center in Baltimore. |